Stojanović, M. and Bursać, D. (2024) “Immunotoxicity of Pembrolizumab in patients with metastatic non-small cell lung cancer: A single-centre study”, Archive of Oncology, 30(1), pp. 14–18. doi:10.2298/AOO240304006S.